Join us in
transforming
women's health
Let's make period pain a thing of the past.
They are already with us
When periods destroy everyday life
For many women, severe dysmenorrhea (severe menstrual pain) is more than just a temporary discomfort. Affecting around 12% of menstruating women, these pains can become so unbearable that they cause fainting, sweating or vomiting. They seriously interfere with daily life, limiting social and professional activities and often having a strong psychological impact.
of menstruating women suffer from severe dysmenorrhea
The limits of traditional treatments
Current treatment options (such as painkillers like ibuprofen, paracetamol, or combined oral contraceptives) fail to provide effective relief for many women. Between 20% and 25% of women feel no relief at all, and over 30% consider them ineffective. For some, the only remaining solution is major surgery, with high risks and uncertain efficacy.
the number of women suffering from severe dysmenorrhea resistant to traditional treatments.
Growing demand for non-invasive solutions
Severe dysmenorrhea affects a large number of women, and the effectiveness of existing treatments is often limited. The market for pain relief devices therefore represents a significant growth opportunity. Estimated at $10.5 billion in 2023, it should reach $18.8 billion by 2031, highlighting the strong economic potential of innovative solutions like EVA
Market trends are aligned with Mirapulse
Increased awareness of menstrual health:
Growing awareness of menstrual health is generating strong demand for solutions that improve women's quality of life.
Increasing prevalence of chronic pain conditions :
With chronic pain on the rise, the need for effective, targeted solutions is greater than ever.
Trend towards non-pharmaceutical solutions :
Consumers are increasingly looking for alternatives to drugs, preferring natural solutions with no side effects.
Integration of wearable technology :
The integration of wearable technology into the menstrual pain relief device market is rapidly gaining traction, reflecting broader trends in the health and wellness sectors.
Technological advances :
Advances in technology have made it possible to develop high-performance, affordable devices, positioning EVA as an innovative and relevant solution for the relief of severe menstrual pain.
Scientific collaboration and rigorous development
The development of EVA is based on close collaboration with renowned medical experts and specialized research centers. By working hand-in-hand with clinics and specialists in women's health, particularly in the field of endometriosis, we ensure that every stage of development benefits from the expertise and scientific rigor needed to create a reliable and effective product. This collaborative approach ensures that EVA is not only an innovative solution, but also meets patients' needs and expectations in a concrete and verifiable way.
A long-term vision for women's health
At Mirapulse, we see far beyond the simple creation of a product. We have an ambitious vision for the future of women's health: to develop cutting-edge solutions that transform the quality of life of millions of women. EVA is just the first step on this journey. Our commitment to continuous innovation drives us to explore new applications for our technology and to always push the boundaries to meet the complex and varied needs of patients.
Invest in the future of women's health
Would you like to be part of a revolution in women's health? Join Mirapulse and contribute to our mission to fight menstrual pain.
Together, we can transform the lives of millions of patients through cutting-edge technology. Discover how your investment can redefine the future of women's health and make a real difference.
.webp)